Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Sweden
Finland
Denmark
Norway
Latest
Trending
Followed

Arjo, Audiocast, Q3'26

By Inderes10/22/2026, 6:00 AM
Arjo

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Andréas Elgaard
00:00 - 05:06

Thanks for joining our Q3 call, and we are happy to report that we have solid growth. A lot of good news to share with you today. So I think we can head into the presentation. As usual, we will begin with a few words to remind everybody about who we are. At Arjo, we are guided by a real and living strong purpose. That is something that is. Driving a lot of the commitment and passion across all our coworkers. We exist really when we are needed most by our customers, when they need someone to help them with their integrity and dignity when they are in their most vulnerable position. And that is something that is really strong and important across our group. We are experts in mobility care settings, and every day we are working in healthcare systems that are put under a lot of pressure as the need for patient care is growing. The number of patients that need care is growing. The money that flows into the system is not enough to meet the needs, which is favorable for us. It is a growing need. And this is regardless of how the economy performs around us, the need is still continuing to grow. We are a company that has been around for a while. We are soon going to have a celebration next year to celebrate our 70 years of operation. As a company, we have 11 billion in turnover, around 7,000 employees, and we sell to more than 100 countries. We manufacture and assemble our products in five facilities across three continents. So now we will move to the Q3 presentation. We will start with some of the key takeaways. So, of course, the growth is what stands out this quarter. With 6% organic growth. We are really proud of that. We also see that the gross margin is healthy in the quarter. Of course, the gross margin has been slightly boosted by tariff refunds of approximately 3.7 million USD in the quarter. It is also important to mention that, perhaps less positively, we have conducted a re-evaluation of our assets held in Atlas Mobility and Veplas. And that has affected us on the net financial items side, and at the Capital Markets Day a few weeks ago, we shared our new strategy in the direction that we will take for the coming years. That is really focusing on improving our performance and building a more scalable platform. And we at that time communicated a 350 MSEK commitment of operating profit improvements until H1 2029. We are continuing to prepare for change and to drive change, and we are adjusting our operating model. We are changing the roles and responsibilities across the group, and that also leads to changes at the group management level, where we are trying to strengthen and focus on the job we have for the next few years. It is also worth mentioning that we have recently shared with all of you that we are introducing new segment reporting divided into three parts. So North America, Europe, and our international and distributed markets. Please move to the next slide. So, just to continue a little bit to shed some light on the quarter. So North America was really a big part of leading the growth, especially given the size of the business there, together with Europe, and Europe had a really strong month. And you can also see that year-to-date, we are on a very good path this quarter. Our international and distributed markets did not have similarly strong growth. But year to date, they are performing well. And I think that is also important to mention that you need to look at us. Maybe not just quarter by quarter, but to see the trend that we are on. So I think by that, it is time for me to hand over to Christofer. Thank you, Andréas.

Christofer Carlsson
05:08 - 09:55

As Andréas Elgaard noted, we delivered solid growth during the quarter. Our gross margin increased by 1.9% year-on-year. During the quarter, we received reimbursement of approximately 35 million SEK related to US tariffs. The reimbursement was recognized as a reduction in cost of goods sold, consistent with the treatment in the second quarter. Excluding reimbursement, tariff costs were approximately 11 million SEK lower than in the corresponding quarter last year. The total gross margin impact from US tariffs was 1.6%. The remaining gross margin improvement was driven by a favorable sales mix, supported by strong growth in capital sales, with patient handling the main contributor. Higher transportation costs across all categories partly offset the benefit of the favorable sales mix. FX provided a tailwind during the quarter. It had no impact on gross margin, but increased gross profit by approximately 16 MSEK year on year. In summary, gross margin improved even if we exclude US tariff effects, despite higher transportation costs. This means that we had a healthy underlying development driven by good momentum in our Patient Handling business. Let's now turn to the adjusted EBIT and operating expenses. Next slide, please. Adjusted EBIT for the third quarter amounted to 247 MSEK, compared to 165 MSEK last year. Higher gross profit was the main driver of the improvement. A lower operating expense to sales ratio also contributed, while strong capital sales led to higher variable sales costs. Overall, FX increased adjusted EBIT by approximately 50 million during the quarter. The positive impact on the adjusted EBIT margin was 0.5% from FX, excluding FX and the US tariff reimbursement. Adjusted EBIT amounted to 195 million, with an improved EBIT margin of 6.8% compared to 6.2% last year. Turning to EBIT, the margin improved to 7.2% compared to 5.7% last year. This improvement came despite higher restructuring costs of 41 million SEK compared to 30 million SEK last year. The increase mainly reflects costs related to the strategy, review, and activities within our organization. Turning from profitability to cash generation, let's look at working capital and operating cash flow. Operating cash flow increased to 485 million, up 31 million compared with the same period last year. The improvement was driven primarily by strong operating profit, partly offset by less favorable development in working capital. Working capital contributed 67 million SEK to cash flow, compared to 83 million last year. Inventories increased mainly due to finished goods in transit to support sales in the final quarter of the year. Working capital days increased to 88 compared to 82 last year. Cash conversion was 100.4% compared to 105% in the corresponding period last year. On a rolling 12-month basis. Cash conversion will remain above our financial target of 80%. Cash flow from investing activities was -107 million SEK. 77 million SEK compared to 148 million in Q3 2025. I should also mention that, as you have seen, our net financial items amounted to -102 million compared to -41 million in Q3 last year. This included negative revaluation effects, as Andréas earlier talked about, of 62 million SEK related to the investment in Atlas Mobility and Veplas. Both investments now have a carrying value of zero. Net debt to adjusted EBITDA decreased to 2.2 times at the quarter end, and our equity ratio stood at 50.3%, slightly up from 49.8% at year-end. In summary, profitability improved and operating cash flow increased while working capital days rose, and leverage decreased to 2.2 times. With that, I hand it over to Andréas.

Andréas Elgaard
09:56 - 17:15

Thanks, guys. So, I thought that before we open up the floor for questions and answers, I will remind everybody a little bit about what we said when we had the Capital Markets Day a few weeks ago, where we laid out our strategic direction and talked about what to expect from us in the coming years. So, the strategy is really all about a plan to put Arjo back on track. And by that, I mean focusing on where we have our strengths, and building a more focused and lean organization that is concentrating where we have the right to play. And of course, that is within Acute Care. That is our biggest segment. It is within Long-Term Care where we're really successful and profitable, and to make sure that we are more evenly covering that across our countries and markets. We also see opportunities to expand selectively into new care settings. And the reason why I say selectively is that we need to be sure that we will be successful and that we have the right to play, and simplify to amplify as a strategic pillar, I would say, is really focusing on us doing our homework. It is about building a stronger, more focused portfolio and increasing our speed to market. This is an area where Arjo has been struggling for years, and we really need to come together and do this and activate the whole company in the process. Commercial excellence is an area where we see potential all around us, both by leveraging the good examples we have internally, but also by leveraging insights from bringing new competency into the company and understanding what others do better than us that we can learn from. And then we have to become more digital, and we call that becoming a digital and AI-enabled care partner. So this is mainly about how we perform our own job, how we drive our own process, how we drive our own efficiency, but also how we activate this in our offer, in our services going forward. And then, working better together. That is all about us leveraging all the diversity and all the strengths that we have together as a company, and making that work for the benefit of all our stakeholders. We need to be really laser-focused on driving a performance-based culture and to make sure that everybody understands if we are adding value to the customer or not. And this is really important, in order for us to be able to manage both continuous performance and drive transformational change. We are a really strong purpose-led organization. I began this presentation today by talking about that. And we need to continue to strengthen that. One part of doing it is to really focus on our core business that is really delivering on that purpose. But another one is also to contribute to better and more sustainable healthcare. And we have several initiatives that will drive that in the years to come. So what we presented at the Capital Markets Day, in summary, was a 350 MSEK profit improvement that we believe we will be able to deliver by mid-2029. And this is a significant change in unlocking the potential that Arjo has. And this is something that we feel very confident in saying because we know where we will find it, and we have it within our own control. So just to share where this is coming from. So the 350 million SEK will be an EBIT improvement. We received several questions during the Capital Markets Day. If this is on an adjusted or unadjusted level, it does not matter. This is real concrete profit improvement. It will come from our operating model and our re-engineered cost structure. It will come from the potential that we have within procurement, where we see that we have not been focused enough. So there's a lot of potential, and we are already working on that. We see that within commercial excellence, there are many leverage points that we can activate in order to drive value. And just to also then reiterate that these are just the first things that we are addressing and that we felt were so important for us to share at the Capital Markets Day. But we have more things that we need to drive. So our product portfolio optimization, supply chain optimization, capital efficiency, and then clarity on our growth agenda both organically and then, of course, through M&A. So there is further value creation potential in Arjo that we will come back and talk about. And that is also why we will come back in Q1 to present new financial targets. With this improvement, of course, everybody understands that we need to do some restructuring. We need to do some reshuffling of our roles and responsibilities across the group. And the restructuring costs that we have here are conservatively mentioned. So we hope that we will not need all of this, but the majority will happen largely over the coming 18 months. So we will continue to report back to all of you who follow us every quarter. When we start a new year, we will report how we are progressing towards delivering the 350 MSEK and how we are spending the restructuring investments. And all of this is really about trying to create a stronger platform for Arjo so we can drive further expansion. So it does not mean that we wait until 2029. It really means that we need to build a more scalable platform where we are focusing on our strengths and where we have our strongest customer and market positions. And based on that, we will be able to scale up and add more for the future. Arjo. So we can take the next slide. And that is just to remind everyone that, as I mentioned, we will present new financial targets in Q1 2027, and we will give regular updates on our progress in how we are delivering towards the promises we have made. And what you have to look forward to is, of course, the year-end report that comes in the end of January. Then we are presenting the financial targets during Q1, and we have a Q1 report in April 2027. And time will fly very quickly for me. Certainly, this first year at Arjo has just flown by. I think this is the fourth report I am presenting in the nine months. It has been really intense and we have done so much so far. So I just want to say a big thanks to all the co-workers in Arjo for this quarter. And now I think it is time for us to open the floor.

Operator
17:23 - 17:39

If you wish to ask a question, please dial the pound key on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial pound key six on your telephone keypad. The next question comes from Ludvig Lundgren from Arctic. Please go ahead.

Ludvig Lundgren
17:41 - 18:04

Yes. Hi guys. Thank you for taking my questions. I just wanted to hear a bit more on the trends, specifically if you saw any changes, perhaps thinking mostly about the US and Europe side, regarding any shifts in the key markets there? Starting with that one.

Andréas Elgaard
18:06 - 18:52

Yeah. So thank you for your question. I would say that we had positive developments throughout all three months of the quarter. And I think we also came from a strong finish in Q2. So I would say that we carry that momentum with us into Q3. So we have not seen any particular trends that. So that has not changed how we have presented the business from before. It is clear that patient handling is what is driving strong results in this quarter. And that is also explaining the growth in key markets where we are strong in patient handling, but also the margin that comes from that.

Ludvig Lundgren
18:55 - 19:17

Okay, great. Very clear. And then I just had—maybe it's too early to say—but I guess the flu season was quite weak last year, in particular in the US. Do you have any indicators to suggest how you expect the flu season to unfold this year? I guess in some regions, we are already seeing effects of this.

Andréas Elgaard
19:18 - 19:53

So no, we don't have that. We think that, during Q3, we don't have anything typical that happens now in this quarter. So, we are all, of course, hoping that everybody will stay safe and, also, we are of course hoping that we have a more normal situation compared to what we had last year. But this is something that we don't really influence. So, it can really make or break the fourth quarter. Yeah.

Ludvig Lundgren
19:54 - 19:57

Okay. Fair enough. Those were my questions. I will jump back to the queue.

Andréas Elgaard
19:57 - 20:00

Thank you very much, Ludwig.

Operator
20:02 - 20:08

There are no more questions at this time. So I hand the conference back to the speakers for any closing comments.

Andréas Elgaard
20:10 - 20:25

I just want to say a big thanks for listening in to us today. Or if you're listening to the recorded version of this. So we are happy with the quarter that we are presenting, and we are looking forward to ending the year. So a big thanks to everybody. Bye-bye.

Christofer Carlsson
20:26 - 20:27

Thank you. Bye.

Continue to the webcast
Pierce Group, Audiocast, Q3'26
Language: English11/13/2026, 8:00 AM
Göran Dahlin Good morning, everyone, and welcome to Pierce Group's presentation of our Q3 2026 interim results. Next slide, please. I am Göran Dahlin, CEO of Pierce Group, and I am with Fredrik Kjellg…
Surgical Science Sweden, Audiocast, Q3'26
Language: English11/12/2026, 10:00 AM
Tom Englund Hi everyone, and welcome to this earnings call for Surgical Science for the third quarter of 2026. My name is Tom Englund. I am the CEO. And with me today is our CFO, Anna Ahlberg. I wil…
ExpreS2ion Biotech – Presentation of Q3 2026 Interim Report
Language: English11/12/2026, 9:00 AM
ExpreS2ion is expected to release its Q3 2026 interim report on 12 November 2026. Later the same day at 10.00, ExpreS2ion’s CEO Bent U. Frandsen and CFO Keith Alexander will present the results and answer questions in a live online event.
Meko Services AB, Q3'26
Language: English11/12/2026, 8:00 AM
Pat Thank you. Good morning, and welcome to MEKO's presentation of the third quarter of 2026. I am here with our CFO, Christy Johansson, and I will begin with an overview of the quarter and some of th…
WeSports Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Unknown 1 It. Ted Sporre Welcome to our Q3 release presentation. As you know, we have already shared preliminary figures for sales and EBITDA for this quarter, but today we complete the picture. We wi…
Nordrest Holding, Audiocast, Q3'26
Language: Swedish11/12/2026, 8:00 AM
Thomas Dahlstedt Hej och välkomna! Vi ska idag presentera Nordrests senaste kvartal och tillika resultatet för perioden. Jag som pratar nu heter Thomas Dahlstedt och är grundare och tillika VD för bol…
Karnov Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Pontus Bodelsson Welcome, everyone, to Karnov Group's earnings conference, where we will present the outcome of the third quarter of 2026. Please go to slide two. I am Pontus Bodelsson, President and…
Fasadgruppen Group, Audiocast, Q3'26
Language: English11/12/2026, 7:15 AM
Magnus Blomberg Perfect. Good morning and welcome to the Fasadgruppen presentation of our results for the third quarter 2026. My name is Magnus Blomberg. You have met me before. I am the CFO of Fasadg…
Munters AB, CMD
Language: English11/11/2026, 1:00 PM
Lena Dauvergne Good. Good afternoon everyone, and a warm welcome to Stockholm, to ESSEX and to Montage Capital Markets Day 2026. Montage Capital Markets Day 2026. It is really good to see so many of y…
Cinclus Pharma, Audiocast, Q3'26
Language: English11/11/2026, 1:00 PM
Christer Ahlberg Thank you. Hello and welcome to the Cinclus Pharma third quarter 2026 earnings call. I am Christer Ahlberg, CEO of Cinclus Pharma, and with me today is our CFO, Magnus Christensen. We…
Proact IT, CMD
Language: English11/11/2026, 12:30 PM
Unknown 1 The world of data is constantly changing. Breaches are rising, and attacks are getting more advanced. Regulation drives the need for data sovereignty. Data has to be available. Critical busi…
Ferronordic AB, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Henrik Good morning, everyone, and welcome to our presentation of the third quarter of 2026. During the quarter, we saw higher earnings, and growing aftermarket revenue was up 15% to 1.2 billion Swedi…
BICO, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Anders Fogelberg Good morning, everyone, and welcome to BICO's earnings call for the third quarter of 2026. I am Anders Fogelberg, President and CEO of BICO. And joining me today is our Group CFO, Ewa…
Catena Media, Audiocast, Q3'26
Language: English11/10/2026, 5:00 PM
Manuel Stan Good afternoon. Good evening, everyone. Welcome to the Catena Media Q3 Interim Report. I am Manuel Stan and today I'm joined by our Chief Financial Officer, Michael Gerrow. Today we will b…
Ellos Group, Q3'26
Language: English11/10/2026, 8:00 AM
Hans Ohlsson Live. Good morning, everyone, and welcome to the second presentation for Ellos Group as a listed company. We have 45 minutes today for the presentation. And there is a hard stop. After th…
Scandic Hotels Group, Audiocast, Q3'26
Language: English11/10/2026, 8:00 AM
Jens Mathisen Thank you so much, and good morning, everyone, and thank you for joining us for the Q3 presentation. I am Jens Mathisen, CEO of Scandic. And joining me is our CFO, Pierre Carstensen. We…
Svevik Industri, Q3'26
Language: Swedish11/6/2026, 9:00 AM
Johan Hårdén Tack så mycket! Hello and welcome to this hearing regarding the Q3 2026 interim report. We have an agenda where we intend to introduce ourselves to all the new shareholders as well. Kort…
Attendo, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Martin Tivéus Good morning, everyone, and thank you for joining us. Today, we will present our results for the third quarter of 2026. I am pleased to announce that this is the strongest quarter for At…
Cavotec, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
David Pagels Good morning and welcome to Cavotec's Q3 2026 presentation. I am David Pagels, the CEO of Cavotec. And together with me today, I have our new CFO, Christoffer Robertsson. I would like to…
Fractal Gaming Group, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Jonas Good morning, everyone, and welcome to Fractal's Q3 2026 presentation. Today, we'll take you through our results, the progress that we've made, and our priorities ahead after a difficult first h…